These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 21869839

  • 21. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
    Lazo G, Kantarjian H, Estey E, Thomas D, O'Brien S, Cortes J.
    Cancer; 2003 May 01; 97(9):2218-24. PubMed ID: 12712474
    [Abstract] [Full Text] [Related]

  • 22. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H, Li K, Mei C, Wang H, Chen Z, Jin J.
    Ann Hematol; 2011 Dec 01; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract] [Full Text] [Related]

  • 23. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
    Woo SH, Park IC, Park MJ, Lee HC, Lee SJ, Chun YJ, Lee SH, Hong SI, Rhee CH.
    Int J Oncol; 2002 Jul 01; 21(1):57-63. PubMed ID: 12063550
    [Abstract] [Full Text] [Related]

  • 24. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.
    Haematologica; 2005 Dec 01; 90(12):1607-16. PubMed ID: 16330433
    [Abstract] [Full Text] [Related]

  • 25. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
    Li L, Wang J, Ye RD, Shi G, Jin H, Tang X, Yi J.
    J Cell Physiol; 2008 Nov 01; 217(2):486-93. PubMed ID: 18636556
    [Abstract] [Full Text] [Related]

  • 26. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.
    Zhao WL, Chen SJ, Shen Y, Xu L, Cai X, Chen GQ, Shen ZX, Chen Z, Wang ZY.
    Leuk Lymphoma; 2001 Nov 01; 42(6):1265-73. PubMed ID: 11911407
    [Abstract] [Full Text] [Related]

  • 27. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
    Zhang P.
    J Biol Regul Homeost Agents; 1999 Nov 01; 13(4):195-200. PubMed ID: 10703942
    [Abstract] [Full Text] [Related]

  • 28. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt.
    Choi YJ, Park JW, Suh SI, Mun KC, Bae JH, Song DK, Kim SP, Kwon TK.
    Int J Oncol; 2002 Sep 01; 21(3):603-10. PubMed ID: 12168106
    [Abstract] [Full Text] [Related]

  • 29. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T, Kees M, Gisslinger H.
    Leuk Lymphoma; 2002 Aug 01; 43(8):1535-40. PubMed ID: 12400595
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of action of all-trans retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Wang ZY.
    Gan To Kagaku Ryoho; 2002 Feb 01; 29 Suppl 1():214-8. PubMed ID: 11890109
    [Abstract] [Full Text] [Related]

  • 31. Involvement of Ca2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization.
    Gogvadze V, Norberg E, Orrenius S, Zhivotovsky B.
    Int J Cancer; 2010 Oct 15; 127(8):1823-32. PubMed ID: 20104525
    [Abstract] [Full Text] [Related]

  • 32. The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.
    Angulo-Molina A, Reyes-Leyva J, López-Malo A, Hernández J.
    Nutr Cancer; 2014 Oct 15; 66(2):167-76. PubMed ID: 24364743
    [Abstract] [Full Text] [Related]

  • 33. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C, Vermes I.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1738-41. PubMed ID: 10494320
    [Abstract] [Full Text] [Related]

  • 34. [Acute promyelocytic leukemia--modern approach to disease pathogenesis and differentiation treatment].
    Podhorecka M, Macheta A.
    Postepy Hig Med Dosw (Online); 2013 Nov 25; 67():1083-9. PubMed ID: 24379249
    [Abstract] [Full Text] [Related]

  • 35. PML nuclear bodies mediate the therapeutic response of APL cells.
    Cancer Discov; 2014 Mar 25; 4(3):OF20. PubMed ID: 24596215
    [Abstract] [Full Text] [Related]

  • 36. APL, a model disease for cancer therapies?
    de Thé H, Chelbi-Alix MK.
    Oncogene; 2001 Oct 29; 20(49):7136-9. PubMed ID: 11704841
    [No Abstract] [Full Text] [Related]

  • 37. Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II.
    Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, Goodwin J, Brunk UT, Witting PK, Moreno-Sanchez R, Scheffler IE, Ralph SJ, Neuzil J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1593-600. PubMed ID: 19223492
    [Abstract] [Full Text] [Related]

  • 38. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.
    Golemovic M, Quintás-Cardama A, Manshouri T, Orsolic N, Duzkale H, Johansen M, Freireich EJ, Kantarjian H, Zingaro RA, Verstovsek S.
    Invest New Drugs; 2010 Aug 01; 28(4):402-12. PubMed ID: 19468689
    [Abstract] [Full Text] [Related]

  • 39. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Diaz Z, Laurenzana A, Mann KK, Bismar TA, Schipper HM, Miller WH.
    Leukemia; 2007 Oct 01; 21(10):2117-27. PubMed ID: 17690699
    [Abstract] [Full Text] [Related]

  • 40. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy.
    Kovarova J, Bajzikova M, Vondrusova M, Stursa J, Goodwin J, Nguyen M, Zobalova R, Pesdar EA, Truksa J, Tomasetti M, Dong LF, Neuzil J.
    Redox Rep; 2014 Jan 01; 19(1):16-25. PubMed ID: 24225203
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.